UK U-turn on single use for vCJD (variant Creutzfeldt-Jakob disease)-risk surgery
This article was originally published in Clinica
Executive Summary
The UK Department of Health is to reintroduce reusable surgical instruments for tonsil and adenoid surgery, thus overturning its decision of almost a year ago to introduce single-use devices to eliminate the risk of patient-to-patient transmission of vCJD in these procedures. The decision has been prompted by the high number of adverse events attributed to the use of single-use instruments in the past year. It is based on the "balance of risks" to patients, says the DoH, on the advice of the British Association of Otorhinolaryngologists.
You may also be interested in...
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.